These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 10227773

  • 1. The effect of selective low-density lipoprotein apheresis on plasma lipoperoxides and antioxidant vitamins in familial hypercholesterolemic patients.
    Baricchi R, Pizzala R, Cacciavillani G, Rivasi P, Tomasi A.
    Ther Apher; 1998 Aug; 2(3):218-23. PubMed ID: 10227773
    [Abstract] [Full Text] [Related]

  • 2. The Effect of LDL-Apheresis and Rheohaemapheresis Treatment on Vitamin E.
    Solichová D, Bláha M, Aufartová J, Krcmová LK, Plíšek J, Honegrová B, Kasalová E, Lánská M, Urbánek L, Sobotka L.
    J Nutr Sci Vitaminol (Tokyo); 2015 Aug; 61(2):105-12. PubMed ID: 26052140
    [Abstract] [Full Text] [Related]

  • 3. Blood antioxidants (vitamin E and beta-carotene) in long-term low density lipoprotein apheresis.
    Assogba U, Lepage S, Bruckert E, Bonnefont-Rousselot D, Dairou F, de Gennes JL, Delattre J.
    Clin Chim Acta; 1995 Mar 31; 235(2):147-57. PubMed ID: 7554269
    [Abstract] [Full Text] [Related]

  • 4. [LDL oxidation in homozygous familial hypercholesterolemia: effects of selective LDL-apheresis treatment].
    Napoli C, Postiglione A, Scarpato N, Corso G, Ambrosio G, Condorelli M, Mancini M, Chiariello M.
    Cardiologia; 1996 May 31; 41(5):435-9. PubMed ID: 8767632
    [Abstract] [Full Text] [Related]

  • 5. Effects of LDL-immunoapheresis on plasma concentrations of vitamin E and carotenoids in patients with familial hypercholesterolemia.
    Cauza E, Jansen M, Resch U, Dunky A, Derfler K, Winklhofer-Roob BM, Kostner K.
    J Clin Apher; 2004 May 31; 19(4):174-9. PubMed ID: 15597350
    [Abstract] [Full Text] [Related]

  • 6. Single LDL apheresis improves serum remnant-like particle-cholesterol, C-reactive protein, and malondialdehyde-modified-low-density lipoprotein concentrations in Japanese hypercholesterolemic subjects.
    Kobayashi J, Katsube S, Shimoda M, Furuhashi K, Kitano S, Masuda M, Maruyama T, Shinomiya M.
    Clin Chim Acta; 2002 Jul 31; 321(1-2):107-12. PubMed ID: 12031599
    [Abstract] [Full Text] [Related]

  • 7. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
    Stefanutti C, Di Giacomo S, Vivenzio A, Isacchi GC, Masella R, Caprari P, Varì R, Tarzia A, Mosiello A, Cantafora A.
    Clin Sci (Lond); 2001 Feb 31; 100(2):191-8. PubMed ID: 11171288
    [Abstract] [Full Text] [Related]

  • 8. Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS).
    Nishimura S, Sekiguchi M, Kano T, Ishiwata S, Nagasaki F, Nishide T, Okimoto T, Kutsumi Y, Kuwabara Y, Takatsu F, Nishikawa H, Daida H, Yamaguchi H.
    Atherosclerosis; 1999 Jun 31; 144(2):409-17. PubMed ID: 10407502
    [Abstract] [Full Text] [Related]

  • 9. Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia.
    Zwiener RJ, Uauy R, Petruska ML, Huet BA.
    J Pediatr; 1995 May 31; 126(5 Pt 1):728-35. PubMed ID: 7751996
    [Abstract] [Full Text] [Related]

  • 10. Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia.
    Napoli C, Ambrosio G, Scarpato N, Corso G, Palumbo G, D'Armiento FP, Mancini FP, Malorni A, Formisano S, Ruocco A, Calí A, Chiariello M.
    Am Heart J; 1997 May 31; 133(5):585-95. PubMed ID: 9141382
    [Abstract] [Full Text] [Related]

  • 11. Platelet aggregation and lipoprotein levels in a patient with familial hypercholesterolemia after selective LDL-apheresis.
    Pares MN, D'Amico EA, Kutner JM, Chamone Dde A, Bydlowski SP.
    Sao Paulo Med J; 1997 May 31; 115(3):1448-51. PubMed ID: 9532848
    [Abstract] [Full Text] [Related]

  • 12. [H.E.L.P. apheresis and oxidative stress].
    Pulawski E, Mellwig KP, Horstkotte D.
    Z Kardiol; 2003 May 31; 92(Suppl 3):III38-41. PubMed ID: 14663600
    [Abstract] [Full Text] [Related]

  • 13. Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: impact of long-term low-density lipoprotein apheresis.
    Lepage S, Nigon F, Bonnefont-Rousselot D, Assogba U, Goulinet S, Chancharme L, Delattre J, Bruckert E, Chapman MJ.
    J Cardiovasc Pharmacol Ther; 2000 Apr 31; 5(2):87-103. PubMed ID: 11150388
    [Abstract] [Full Text] [Related]

  • 14. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.
    Kitabatake A, Sato H, Hori M, Kamada T, Kubori S, Hoki N, Minamino T, Yamada M, Kato T.
    Clin Ther; 1994 Apr 31; 16(3):416-28. PubMed ID: 7923308
    [Abstract] [Full Text] [Related]

  • 15. Acute effects of LDL-apheresis on cholesterol oxidation products and antioxidants in plasma and lipoproteins of patients with familial hypercholesterolemia.
    Linseisen J, Wilhelm M, Hoffmann J, Hailer S, Keller C, Wolfram G.
    Eur J Med Res; 1999 Oct 15; 4(10):433-41. PubMed ID: 10527957
    [Abstract] [Full Text] [Related]

  • 16. Changes in serum afamin and vitamin E levels after selective LDL apheresis.
    Varga VE, Lőrincz H, Szentpéteri A, Juhász L, Seres I, Paragh G, Balla J, Paragh G, Harangi M.
    J Clin Apher; 2018 Oct 15; 33(5):569-575. PubMed ID: 30247793
    [Abstract] [Full Text] [Related]

  • 17. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
    Hussein H, Saheb S, Couturier M, Atassi M, Orsoni A, Carrié A, Therond P, Chantepie S, Robillard P, Bruckert E, Chapman MJ, Kontush A.
    J Clin Lipidol; 2016 Oct 15; 10(1):124-33. PubMed ID: 26892129
    [Abstract] [Full Text] [Related]

  • 18. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.
    Mabuchi H, Koizumi J, Shimizu M, Kajinami K, Miyamoto S, Ueda K, Takegoshi T.
    Am J Cardiol; 1998 Dec 15; 82(12):1489-95. PubMed ID: 9874053
    [Abstract] [Full Text] [Related]

  • 19. Treatment of homozygous familial hypercholesterolemia with low density lipoprotein apheresis: a 4 year follow-up study.
    Fadul JE, Vessby B, Wikström B, Danielson BG.
    Artif Organs; 1997 May 15; 21(5):364-8. PubMed ID: 9129767
    [Abstract] [Full Text] [Related]

  • 20. In vivo rheologic effects of lipid apheresis techniques: comparison of dextran sulfate LDL adsorption and heparin induced LDL precipitation.
    Grützmacher P, Landgraf H, Esser R, Okon J, Vlachojannis J, Ehrly AM, Schoeppe W.
    ASAIO Trans; 1990 May 15; 36(3):M327-30. PubMed ID: 2252691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.